ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,412, issued on Feb. 24, was assigned to Seqirus UK Ltd. (Berkshire, Great Britain).
"Vaccination of immunocompromised subjects" was invented by Giuseppe Del Giudice (Berkshire, Great Britain), Rino Rappuoli (Berkshire, Great Britain), Steven Black (Berkshire, Great Britain) and Uwe Nicolay (Berkshire, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for enhancing immune responses to a vaccine in immunocompromised individuals, including those receiving a statin therapy. Related products are also provided."
The patent was filed on April 18, 2025, under Application No. 19/182,766.
*For further information, inc...